Kingfa Science & Technology (India) Limited (KINGFA) - Net Assets
Based on the latest financial reports, Kingfa Science & Technology (India) Limited (KINGFA) has net assets worth Rs12.95 Billion INR (≈ $140.00 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs17.35 Billion ≈ $187.59 Million USD) and total liabilities (Rs4.40 Billion ≈ $47.59 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Kingfa Science & Technology (India) Limi liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rs12.95 Billion |
| % of Total Assets | 74.63% |
| Annual Growth Rate | 20.81% |
| 5-Year Change | 106.14% |
| 10-Year Change | 510.99% |
| Growth Volatility | 304.12 |
Kingfa Science & Technology (India) Limited - Net Assets Trend (2006–2025)
This chart illustrates how Kingfa Science & Technology (India) Limited's net assets have evolved over time, based on quarterly financial data. Also explore KINGFA total asset value for the complete picture of this company's asset base.
Annual Net Assets for Kingfa Science & Technology (India) Limited (2006–2025)
The table below shows the annual net assets of Kingfa Science & Technology (India) Limited from 2006 to 2025. For live valuation and market cap data, see Kingfa Science & Technology (India) Limi market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | Rs7.30 Billion ≈ $78.91 Million |
+23.98% |
| 2024-03-31 | Rs5.89 Billion ≈ $63.65 Million |
+26.31% |
| 2023-03-31 | Rs4.66 Billion ≈ $50.40 Million |
+21.17% |
| 2022-03-31 | Rs3.85 Billion ≈ $41.59 Million |
+8.65% |
| 2021-03-31 | Rs3.54 Billion ≈ $38.28 Million |
+1.55% |
| 2020-03-31 | Rs3.49 Billion ≈ $37.70 Million |
+7.43% |
| 2019-03-31 | Rs3.24 Billion ≈ $35.09 Million |
+6.29% |
| 2018-03-31 | Rs3.05 Billion ≈ $33.02 Million |
+132.58% |
| 2017-03-31 | Rs1.31 Billion ≈ $14.20 Million |
+9.91% |
| 2016-03-31 | Rs1.19 Billion ≈ $12.92 Million |
+1363.05% |
| 2015-03-31 | Rs81.63 Million ≈ $882.79K |
-28.34% |
| 2014-03-31 | Rs113.91 Million ≈ $1.23 Million |
-42.67% |
| 2013-03-31 | Rs198.68 Million ≈ $2.15 Million |
-20.26% |
| 2012-03-31 | Rs249.16 Million ≈ $2.69 Million |
+0.10% |
| 2011-03-31 | Rs248.91 Million ≈ $2.69 Million |
+2.47% |
| 2010-03-31 | Rs242.91 Million ≈ $2.63 Million |
-1.56% |
| 2009-03-31 | Rs246.76 Million ≈ $2.67 Million |
-7.08% |
| 2008-03-31 | Rs265.57 Million ≈ $2.87 Million |
+20.10% |
| 2007-03-31 | Rs221.12 Million ≈ $2.39 Million |
+10.05% |
| 2006-03-31 | Rs200.92 Million ≈ $2.17 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Kingfa Science & Technology (India) Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 454944300000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rs4.55 Billion | 62.44% |
| Common Stock | Rs121.11 Million | 1.66% |
| Other Comprehensive Income | Rs15.43 Million | 0.21% |
| Other Components | Rs2.60 Billion | 35.69% |
| Total Equity | Rs7.29 Billion | 100.00% |
Kingfa Science & Technology (India) Limited Competitors by Market Cap
The table below lists competitors of Kingfa Science & Technology (India) Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PSI Software AG
F:PSAN
|
$700.76 Million |
|
Citycon Oyj
HE:CTY1S
|
$700.87 Million |
|
Beijing Career International Co Ltd
SHE:300662
|
$700.97 Million |
|
BioAge Labs, Inc
NASDAQ:BIOA
|
$701.02 Million |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
$700.19 Million |
|
Materials Analysis Technology
TWO:3587
|
$700.15 Million |
|
Beijing Bayi Space LCD Technology Co Ltd
SHG:688181
|
$699.98 Million |
|
CSB Bank Limited
NSE:CSBBANK
|
$699.76 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Kingfa Science & Technology (India) Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,885,759,000 to 7,286,089,000, a change of 1,400,330,000 (23.8%).
- Net income of 1,528,552,000 contributed positively to equity growth.
- Dividend payments of 120,537,000 reduced retained earnings.
- Other comprehensive income decreased equity by 112,276,000.
- Other factors increased equity by 104,591,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rs1.53 Billion | +20.98% |
| Dividends Paid | Rs120.54 Million | -1.65% |
| Other Comprehensive Income | Rs-112.28 Million | -1.54% |
| Other Changes | Rs104.59 Million | +1.44% |
| Total Change | Rs- | 23.79% |
Book Value vs Market Value Analysis
This analysis compares Kingfa Science & Technology (India) Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.94x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 166.57x to 7.94x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-03-31 | Rs28.69 | Rs4779.10 | x |
| 2007-03-31 | Rs31.57 | Rs4779.10 | x |
| 2008-03-31 | Rs37.92 | Rs4779.10 | x |
| 2009-03-31 | Rs35.32 | Rs4779.10 | x |
| 2010-03-31 | Rs35.33 | Rs4779.10 | x |
| 2011-03-31 | Rs36.20 | Rs4779.10 | x |
| 2012-03-31 | Rs36.24 | Rs4779.10 | x |
| 2013-03-31 | Rs28.89 | Rs4779.10 | x |
| 2014-03-31 | Rs16.57 | Rs4779.10 | x |
| 2015-03-31 | Rs12.46 | Rs4779.10 | x |
| 2016-03-31 | Rs149.85 | Rs4779.10 | x |
| 2017-03-31 | Rs127.53 | Rs4779.10 | x |
| 2018-03-31 | Rs254.07 | Rs4779.10 | x |
| 2019-03-31 | Rs267.93 | Rs4779.10 | x |
| 2020-03-31 | Rs287.83 | Rs4779.10 | x |
| 2021-03-31 | Rs292.28 | Rs4779.10 | x |
| 2022-03-31 | Rs317.55 | Rs4779.10 | x |
| 2023-03-31 | Rs384.77 | Rs4779.10 | x |
| 2024-03-31 | Rs485.98 | Rs4779.10 | x |
| 2025-03-31 | Rs601.60 | Rs4779.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Kingfa Science & Technology (India) Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 20.98%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.76%
- • Asset Turnover: 1.51x
- • Equity Multiplier: 1.59x
- Recent ROE (20.98%) is above the historical average (0.70%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 13.02% | 3.24% | 1.44x | 2.78x | Rs6.08 Million |
| 2007 | 13.27% | 2.94% | 1.65x | 2.73x | Rs7.24 Million |
| 2008 | 20.19% | 4.60% | 1.46x | 3.00x | Rs27.06 Million |
| 2009 | -7.43% | -1.55% | 1.52x | 3.15x | Rs-43.01 Million |
| 2010 | -0.06% | -0.01% | 1.40x | 3.21x | Rs-24.44 Million |
| 2011 | 4.21% | 0.75% | 1.48x | 3.78x | Rs-14.41 Million |
| 2012 | 0.10% | 0.02% | 1.70x | 3.53x | Rs-24.67 Million |
| 2013 | -25.41% | -3.22% | 1.85x | 4.27x | Rs-70.35 Million |
| 2014 | -74.42% | -4.77% | 1.74x | 8.98x | Rs-96.16 Million |
| 2015 | -37.27% | -1.39% | 1.82x | 14.74x | Rs-38.58 Million |
| 2016 | 9.04% | 3.44% | 1.36x | 1.93x | Rs-11.43 Million |
| 2017 | 9.02% | 2.77% | 1.06x | 3.07x | Rs-12.91 Million |
| 2018 | 8.07% | 4.10% | 1.25x | 1.58x | Rs-58.89 Million |
| 2019 | 5.87% | 2.72% | 1.27x | 1.70x | Rs-133.94 Million |
| 2020 | 7.06% | 3.32% | 1.24x | 1.71x | Rs-102.42 Million |
| 2021 | 1.50% | 0.85% | 0.93x | 1.90x | Rs-300.76 Million |
| 2022 | 7.97% | 2.92% | 1.20x | 2.28x | Rs-78.25 Million |
| 2023 | 17.47% | 5.80% | 1.39x | 2.17x | Rs348.11 Million |
| 2024 | 20.82% | 8.24% | 1.50x | 1.69x | Rs636.65 Million |
| 2025 | 20.98% | 8.76% | 1.51x | 1.59x | Rs799.94 Million |
Industry Comparison
This section compares Kingfa Science & Technology (India) Limited's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $8,233,598,031
- Average return on equity (ROE) among peers: 14.34%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Kingfa Science & Technology (India) Limited (KINGFA) | Rs12.95 Billion | 13.02% | 0.34x | $700.39 Million |
| Aarti Industries Limited (AARTIIND) | $16.55 Billion | 20.11% | 1.65x | $1.99 Billion |
| Aarti Surfactants Limited (AARTISURF) | $1.11 Billion | 1.88% | 1.36x | $37.34 Million |
| ABM International Limited (ABMINTLLTD) | $161.33 Million | 4.08% | 2.02x | $4.23 Million |
| Advanced Enzyme Technologies Limited (ADVENZYMES) | $1.66 Billion | 30.02% | 1.39x | $420.87 Million |
| Aether Industries Limited (AETHER) | $22.26 Billion | 7.12% | 0.19x | $1.68 Billion |
| Akzo Nobel India Limited (AKZOINDIA) | $9.20 Billion | 20.25% | 0.96x | $1.45 Billion |
| Alkali Metals Limited (ALKALI) | $528.67 Million | 5.51% | 1.00x | $7.38 Million |
| Alkyl Amines Chemicals Limited (ALKYLAMINE) | $980.47 Million | 17.95% | 1.88x | $838.56 Million |
| Ami Organics Limited (AMIORG) | $576.82 Million | 32.06% | 1.70x | $1.18 Billion |
| Anupam Rasayan India Limited (ANURAS) | $29.31 Billion | 4.39% | 0.57x | $1.65 Billion |
About Kingfa Science & Technology (India) Limited
Kingfa Science & Technology (India) Limited manufactures and supplies reinforced polypropylene compounds, thermoplastics elastomers, and personal protective equipment masks and gloves in India. It also offers engineering plastics including ABS, HIPS, PA, PBT, PC and their alloys; biodegradable nitrile gloves and protective coverall; thermoplastic elastomers under the HYPRENE brand name; POM and L… Read more